Answers are grounded in this paper and cite their sources.
Kimchi, a traditional Korean fermented food, is recognized for its metabolic benefits; however, its effects on human immune function remain poorly defined. In this study, we performed single-cell RNA-seq on peripheral blood mononuclear cells from 13 overweight adults using a paired pre/post design in a 12-week randomized, double-blind, placebo-controlled trial. The participants consumed a placebo, spontaneously fermented kimchi powder, or starter culture-fermented kimchi powder. Kimchi enhanced intercellular signaling mediated by antigen-presenting cells, increased antigen uptake, and promoted the upregulation of MHC class II–related genes through the JAK/STAT1–CIITA axis. Single-cell trajectory analysis revealed accelerated CD4+ T cell differentiation toward effector and regulatory phenotypes, whereas CD8+ T cells, B cells, and NK cells remained stable, indicating preserved systemic immune homeostasis. In summary, 12 weeks of kimchi dietary intervention enhanced antigen presentation and remodeled CD4+ T cells without broad systemic activation, providing single-cell evidence of kimchi-induced dietary immunomodulation in humans. The clinical trial was registered at ClinicalTrials.gov ( https://www.clinicaltrials.gov/ ) under the identifier NCT05898802.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: